Catalog IDs: FC-130-1008, FC-130-1003, FC-130-1006, FC-130-1007, WG-321-1001
The TruSeq Amplicon - Cancer Panel enables highly sensitive mutation detection studies of important cancer-related genes, including BRAF, KRAS, and EGFR. Mutations in these genes are linked to many cancers, including melanoma, colorectal, ovarian, and lung cancer.
This protocol is optimized for 250 ng of high quality genomic DNA and at least 250 ng FFPE genomic DNA. Use a fluorometric-based method to quantify input.